Chen, Isan
Pfizer (United States)
3 papers on CoChat
Most cited papers
- Verified
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Finn, R. S., Dering, J., Conklin, D., Kalous, O., Cohen, D. J., Desai, A. J., Ginther, C., Atefi, M., Chen, I., Fowst, C., et al. (2009) · Breast Cancer Research
Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies
Cited by 1,398
- Verified
Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle–coupled loss of IRF4
Huang, X., Di Liberto, M., Jayabalan, D., Liang, J., Ely, S., Bretz, J., Shaffer, A. L., Louie, T., Chen, I., Randolph, S., et al. (2012) · Blood
Multiple Myeloma Research and TreatmentsCancer-related Molecular Pathways
Cited by 102
- Verified
Treatment of growing teratoma syndrome
Vaughn, D. J., Flaherty, K., Lal, P., Gallagher, M., O'Dwyer, P., Wilner, K., Chen, I., & Schwartz, G. (2009) · New England Journal of Medicine
Teratomas and Epidermoid CystsTesticular diseases and treatments
Cited by 82
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free